These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8468122)

  • 21. Marginal zone B cells regulate antigen-specific T cell responses during infection.
    Bankoti R; Gupta K; Levchenko A; Stäger S
    J Immunol; 2012 Apr; 188(8):3961-71. PubMed ID: 22412197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation.
    Böhme MW; Evans DA; Miles MA; Holborow EJ
    Immunology; 1986 Dec; 59(4):583-8. PubMed ID: 3492440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species.
    Shreffler WG; Burns JM; Badaró R; Ghalib HW; Button LL; McMaster WR; Reed SG
    J Infect Dis; 1993 Feb; 167(2):426-30. PubMed ID: 7678428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani.
    Paraguai de Souza E; Bernardo RR; Palatnik M; Palatnik de Sousa CB
    Vaccine; 2001 Apr; 19(23-24):3104-15. PubMed ID: 11312005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
    Bhardwaj S; Vasishta RK; Arora SK
    Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppression in hamsters with progressive visceral leishmaniasis: an evaluation of the role of nitric oxide toward impairment of the lymphoproliferative response.
    Dasgupta S; Mookerjee A; Chowdhury SK; Ghose AC
    Parasitol Res; 1999 Jul; 85(7):594-6. PubMed ID: 10382610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.
    Stäger S; Smith DF; Kaye PM
    J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of antileishmanial IgG antibodies and Leishmania-specific antigens in sera from Yemeni patients with visceral leishmaniasis.
    Azazy AA; Nasher ST; Ishaq A; Bin-Muhanna M; Chance ML
    Ann Trop Med Parasitol; 2003 Oct; 97(7):689-95. PubMed ID: 14613628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
    Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of B-cell Epitope of Leishmania donovani and its application in diagnosis of visceral leishmaniasis.
    Jamal F; Dikhit MR; Singh MK; Shivam P; Kumari S; Pushpanjali S; Dubey AK; Kumar P; Narayan S; Gupta AK; Pandey K; Das VNR; Bimal S; Das P; Singh SK
    J Biomol Struct Dyn; 2017 Dec; 35(16):3569-3580. PubMed ID: 27892844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.
    Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A
    Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection pattern of leishmaniasis in hamsters produced by recent isolates from kala-azar patients in India.
    Ghosh AK; Ghosh DK
    Indian J Med Res; 1987 Jul; 86():14-9. PubMed ID: 3692555
    [No Abstract]   [Full Text] [Related]  

  • 35. [Observation on susceptibilities and immune responses of four strains of mice to the infection of a Leishmania donovani Chinese strain].
    Yi TL; Hu XS; Feng RY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):122-6. PubMed ID: 3837361
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of cyclosporin A in murine visceral leishmaniasis.
    Olivier M; Tanner CE
    Trop Med Parasitol; 1989 Mar; 40(1):32-8. PubMed ID: 2525802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis.
    Srivastava JK; Misra A; Sharma P; Srivastava B; Naik S; Dube A
    Parasitology; 2003 Aug; 127(Pt 2):107-14. PubMed ID: 12954011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
    Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
    Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
    Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
    Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis.
    Keerti ; Yadav NK; Joshi S; Ratnapriya S; Sahasrabuddhe AA; Dube A
    Vaccine; 2018 Apr; 36(17):2293-2299. PubMed ID: 29573875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.